Dr Brian Underdown

Dr Brian Underdown has been appointed chair of the board of directors at the Ontario Genomics Institute, replacing Dr Mark Poznansky who was recently appointed OGI's president and CEO (R$, December 13/10). Underdown is currently managing director of Lumira Capital, a venture capital firm focused on health and life sciences which he joined in 1997. Prior to entering the investment industry, he was assistant VP research at Sanofi Pasteur with responsibility for its Canadian Universities Research program. Underdown has been an OGI board member since 2004….